Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer

被引：0

作者：

Leyvraz, S. ^{[1
]}

Hong, D. S. ^{[2
]}

Shen, L. ^{[3
]}

van Tilburg, C. M. ^{[4
,5
]}

Tan, D. S. W. ^{[6
]}

Kummar, S. ^{[7
]}

Lin, J. J. ^{[8
,9
]}

Doz, F. ^{[10
,11
]}

McDermott, R. ^{[12
,13
]}

Albert, C. M. ^{[14
,15
]}

Berlin, J. ^{[16
]}

Bielack, S. ^{[17
]}

Lassen, U. N. ^{[18
]}

Tahara, M. ^{[19
]}

Norenberg, R. ^{[20
]}

Shurshalina, A. ^{[21
]}

Fellous, M. ^{[22
]}

Nogai, H. ^{[22
]}

Xu, R. ^{[23
]}

Laetsch, T. W. ^{[24
]}

Drilon, A. ^{[25
,26
]}

机构：

[1] Charite Comprehens Canc Ctr, Berlin, Germany

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Minist Educ Beijing,Canc Hosp & Inst, Beijing, Peoples R China

[4] Heidelberg Univ Hosp, Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[5] German Canc Res Ctr, Heidelberg, Germany

[6] Natl Canc Ctr Singapore, Singapore, Singapore

[7] OHSU, Knight Canc Inst, Portland, OR USA

[8] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[9] Harvard Med Sch, Boston, MA 02115 USA

[10] Inst Curie, Paris, France

[11] Univ Paris, Paris, France

[12] St Vincents Univ Hosp, Dublin, Ireland

[13] Canc Trials Ireland, Dublin, Ireland

[14] Seattle Childrens Hosp, Seattle, WA USA

[15] Univ Washington, Sch Med, Seattle, WA USA

[16] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[17] Klinikum Stuttgart Olgahosp, Stuttgart, Germany

[18] Rigshosp, Dept Oncol, Copenhagen, Denmark

[19] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[20] Chrestos Concept GmbH & Co KG, Essen, Germany

[21] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[22] Bayer HealthCare Pharmaceut Inc, Basel, Switzerland

[23] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China

[24] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[25] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[26] Weill Cornell Med Coll, New York, NY USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V101

引用

页码：13 / 13

页数：1

共 50 条

[31] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Drilon, A.
Moreno, V.
Patel, J.
Lassen, U. N.
Solomon, B.
Rosen, L.
Leyvraz, S.
Tan, D. S. W.
Reeves, J. A.
Dima, L.
Brega, N.
Kummar, S.
Farago, A. F.
ANNALS OF ONCOLOGY, 2020, 31 : S834 - S834
[32] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
Tan, D.
Farago, A.
Kummar, S.
Moreno, V.
Patel, J.
Lassen, U.
Solomon, B.
Rosen, L.
Leyvraz, S.
Reeves, J.
Brega, N.
Dima, L.
Childs, B.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S176 - S176
[33] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
Drilon, A.
Moreno, V.
Patel, J.
Lassen, U.
Solomon, B.
Rosen, L.
Leyvraz, S.
Tan, D. S. W.
Reeves, J. A.
Dima, L.
Brega, N.
Kummar, S.
Farago, A. F.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S30 - S31
[34] Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer
Brose, M. S.
Shen, L.
Tan, D. S. W.
Kummar, S.
Lin, J. J.
McDermott, R.
Berlin, J.
Tahara, M.
Lassen, U. N.
Leyvraz, S.
Patel, J. D.
Norenberg, R.
Dima, L.
Brega, N.
Hong, D. S.
Drilon, A.
ANNALS OF ONCOLOGY, 2021, 32 : S600 - S601
[35] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS
Perreault, Sebastien
Drilon, Alexander
Lassen, Ulrik N.
Geoerger, Birgit
Nysom, Karsten
Ora, Ingrid
Gavrilovic, Igor T.
Norenberg, Ricarda
Bernard-Gauthier, Vadim
De la Cuesta, Esther
Laetsch, Theodore W.
Doz, Francois
Van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2022, 24 : 87 - 87
[36] LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS
Perreault, Sebastien
Doz, Francois
Deyell, Rebecca J.
Kebudi, Rejin
Nilsson, Anna
Nysom, Karsten
Geoerger, Birgit
Zhang, Yi-Zhuo
Bernard-Gauthier, Vadim
Neu, Natascha
de la Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2024, 26
[37] Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer: An expanded dataset.
Mascarenhas, Leo
van Tilburg, Cornelis Martinus
Zwaan, Francois Doz C. Michel
Albert, Catherine M.
Blattman, Claudia
Geoerger, Birgit
DuBois, Steven G.
Federman, Noah
Nagasubramanian, Ramamoorthy
Pappo, Alberto S.
Watt, Tanya Carens
Norenberg, Ricarda
Fellous, Marc Mardoche
De la Cuesta, Esther A.
Laetsch, Theodore Willis
Xu, Rui-Hua
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[38] Updated Efficacy, Safety, and Biomarker Analysis in Patients with TRK Fusion Lung Cancer Treated with Larotrectinib
Lin, J. J.
Tan, D. S. W.
Kummar, S.
Moreno, V.
Leyvraz, S.
Dubashi, B.
Parambath, H.
Burcoveanu, D. -I.
Neu, N.
Leserer, S.
Seidel, H.
Mussi, C. E.
Shen, L.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S77 - S77
[39] Extended Follow-up of Efficacy and Safety of Larotrectinib in Patients With TRK Fusion Lung Cancer
Moreno, V.
Lin, J. J.
Tan, D. S. W.
Kummar, S.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Patel, J. D.
Rosen, L.
Solomon, B.
Yachnin, J.
Norenberg, R.
Fellous, M.
Mussi, C. E.
Shen, L.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S473 - S474
[40] Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours
Hong, D. S.
Tahara, M.
Baik, C.
Bauman, J. R.
Gilbert, J.
Brose, M. S.
Grilley-Olson, J. E.
Patil, T.
McDermott, R.
Raez, L. E.
Johnson, J. M.
Shen, L.
Norenberg, R.
Dima, L.
Mussi, C.
Le, X.
Drilon, A. E.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S847 - S848

← 1 2 3 4 5 →